Functional Alterations of Intestinal P-Glycoprotein under Diabetic Conditions
-
- Kobori Takuro
- Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Kobe Gakuin University
-
- Harada Shinichi
- Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Kobe Gakuin University
-
- Nakamoto Kazuo
- Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Kobe Gakuin University
-
- Tokuyama Shogo
- Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Kobe Gakuin University
この論文をさがす
説明
The maintenance of an appropriate serum concentration of a drug is known to be important for its pharmacological effects and the prevention of unexpected adverse effects. Functional alterations of drug transporters and drug-metabolizing enzymes may influence the serum concentration of drugs through changes in its pharmacokinetics and pharmacodynamics (PK/PD). There are many drug transporters expressed in the brain, liver, kidneys, and intestine including ATP-binding cassette (ABC) transporters and solute carriers (SLCs), which contribute to the systemic distribution of various drugs. Furthermore, the expression and function of P-glycoprotein (P-gp), one of the ABC transporters, is altered by environmental factors such as lifestyle and disease. In this review, we have focused on the influence of functional alterations in the intestinal P-gp on the PK/PD of drugs administered via the oral route under diabetic conditions. Altered expression patterns of intestinal P-gp observed under diabetic conditions exhibit pathological stage-dependency. Furthermore, many factors, such as serum glucose, insulin, nitric oxide, and cytokines, influence expression of intestinal P-gp. Finally, to design appropriate and individually targeted pharmacotherapy, it is necessary to consider the influence of alterations in the intestinal P-gp as well as drug metabolizing enzymes under diabetic conditions based on experimental results obtained from fundamental animal research.
収録刊行物
-
- Biological & Pharmaceutical Bulletin
-
Biological & Pharmaceutical Bulletin 36 (9), 1381-1390, 2013
公益社団法人 日本薬学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204632976000
-
- NII論文ID
- 130003361529
-
- NII書誌ID
- AA10885497
-
- COI
- 1:STN:280:DC%2BC3sbksFCqsw%3D%3D
-
- ISSN
- 13475215
- 09186158
-
- NDL書誌ID
- 024791675
-
- PubMed
- 23995645
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可